BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 28937602)

  • 1. Licochalcone A Prevents the Loss of Dopaminergic Neurons by Inhibiting Microglial Activation in Lipopolysaccharide (LPS)-Induced Parkinson's Disease Models.
    Huang B; Liu J; Ju C; Yang D; Chen G; Xu S; Zeng Y; Yan X; Wang W; Liu D; Fu S
    Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28937602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peiminine Protects Dopaminergic Neurons from Inflammation-Induced Cell Death by Inhibiting the ERK1/2 and NF-κB Signalling Pathways.
    Chen G; Liu J; Jiang L; Ran X; He D; Li Y; Huang B; Wang W; Liu D; Fu S
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29534526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vanillin Protects Dopaminergic Neurons against Inflammation-Mediated Cell Death by Inhibiting ERK1/2, P38 and the NF-κB Signaling Pathway.
    Yan X; Liu DF; Zhang XY; Liu D; Xu SY; Chen GX; Huang BX; Ren WZ; Wang W; Fu SP; Liu JX
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson's Disease in Rats.
    Chen G; Liu J; Jiang L; Ran X; He D; Li Y; Huang B; Wang W; Fu S
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tubeimoside I Protects Dopaminergic Neurons Against Inflammation-Mediated Damage in Lipopolysaccharide (LPS)-Evoked Model of Parkinson's Disease in Rats.
    He D; Huang B; Fu S; Li Y; Ran X; Liu Y; Chen G; Liu J; Liu D
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30065205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of Parkinson's disease.
    Kim BW; Koppula S; Kumar H; Park JY; Kim IW; More SV; Kim IS; Han SD; Kim SK; Yoon SH; Choi DK
    Neuropharmacology; 2015 Oct; 97():46-57. PubMed ID: 25983275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polydatin Prevents Lipopolysaccharide (LPS)-Induced Parkinson's Disease via Regulation of the AKT/GSK3β-Nrf2/NF-κB Signaling Axis.
    Huang B; Liu J; Meng T; Li Y; He D; Ran X; Chen G; Guo W; Kan X; Fu S; Wang W; Liu D
    Front Immunol; 2018; 9():2527. PubMed ID: 30455692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Farrerol protects dopaminergic neurons in a rat model of lipopolysaccharide-induced Parkinson's disease by suppressing the activation of the AKT and NF-κB signaling pathways.
    Li Y; Zeng Y; Meng T; Gao X; Huang B; He D; Ran X; Du J; Zhang Y; Fu S; Hu G
    Int Immunopharmacol; 2019 Oct; 75():105739. PubMed ID: 31351366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erinacine A Prevents Lipopolysaccharide-Mediated Glial Cell Activation to Protect Dopaminergic Neurons against Inflammatory Factor-Induced Cell Death In Vitro and In Vivo.
    Lee SL; Hsu JY; Chen TC; Huang CC; Wu TY; Chin TY
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054997
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of Src tyrosine kinase activity by squamosamide derivative FLZ attenuates neuroinflammation in both in vivo and in vitro Parkinson's disease models.
    Tai W; Ye X; Bao X; Zhao B; Wang X; Zhang D
    Neuropharmacology; 2013 Dec; 75():201-12. PubMed ID: 23916477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory effects of BHBA in both in vivo and in vitro Parkinson's disease models are mediated by GPR109A-dependent mechanisms.
    Fu SP; Wang JF; Xue WJ; Liu HM; Liu BR; Zeng YL; Li SN; Huang BX; Lv QK; Wang W; Liu JX
    J Neuroinflammation; 2015 Jan; 12():9. PubMed ID: 25595674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calycosin attenuates MPTP-induced Parkinson's disease by suppressing the activation of TLR/NF-κB and MAPK pathways.
    Yang J; Jia M; Zhang X; Wang P
    Phytother Res; 2019 Feb; 33(2):309-318. PubMed ID: 30421460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin prevents lipopolysaccharide-induced neurodegeneration in the rat substantia nigra by inhibiting the activation of microglia.
    Bai L; Zhang X; Li X; Liu N; Lou F; Ma H; Luo X; Ren Y
    Mol Med Rep; 2015 Jul; 12(1):1002-8. PubMed ID: 25777539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Licochalcone A Attenuates Lipopolysaccharide-Induced Acute Kidney Injury by Inhibiting NF-κB Activation.
    Hu J; Liu J
    Inflammation; 2016 Apr; 39(2):569-74. PubMed ID: 26552405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phytic acid attenuates inflammatory responses and the levels of NF-κB and p-ERK in MPTP-induced Parkinson's disease model of mice.
    Lv Y; Zhang Z; Hou L; Zhang L; Zhang J; Wang Y; Liu C; Xu P; Liu L; Gai X; Lu T
    Neurosci Lett; 2015 Jun; 597():132-6. PubMed ID: 25929185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early glycolytic reprogramming controls microglial inflammatory activation.
    Cheng J; Zhang R; Xu Z; Ke Y; Sun R; Yang H; Zhang X; Zhen X; Zheng LT
    J Neuroinflammation; 2021 Jun; 18(1):129. PubMed ID: 34107997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apocyanin, a Microglial NADPH Oxidase Inhibitor Prevents Dopaminergic Neuronal Degeneration in Lipopolysaccharide-Induced Parkinson's Disease Model.
    Sharma N; Nehru B
    Mol Neurobiol; 2016 Jul; 53(5):3326-3337. PubMed ID: 26081143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-1 attenuates neurodegeneration in Parkinson's disease model by modulating microglial MAPK/IκB/NFκB axis through its carbohydrate-recognition domain.
    Li Y; Chen N; Wu C; Lu Y; Gao G; Duan C; Yang H; Lu L
    Brain Behav Immun; 2020 Jan; 83():214-225. PubMed ID: 31669519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of Glutaredoxin-1 Activates Microglia and Promotes Neurodegeneration: Implications for Parkinson's Disease.
    Gorelenkova Miller O; Behring JB; Siedlak SL; Jiang S; Matsui R; Bachschmid MM; Zhu X; Mieyal JJ
    Antioxid Redox Signal; 2016 Dec; 25(18):967-982. PubMed ID: 27224303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.